Orthokeratology Lens Market

Changning consumer preference for non-surgical vision correction procedures to drive market growth

Orthokeratology lenses are special gas-permeable lenses suitable for all age groups and designed for corneal reshaping. These lenses can be worn overnight, preventing patients from wearing spectacles or contact lenses during the day. Several recent studies have found that orthokeratology treatment is one of the effective ways to slow myopia progression in children. These lenses are also referred to as daytime ortho-K lenses by some healthcare professionals in some nations. Several vision correction surgeries are available for refractive errors like myopia and astigmatism, such as refractive lens exchange, LASIK, and photorefractive keratectomy (PRK).

However, some of the adverse effects of these operations, such as dry eye, itching, blurred glare, vision, and halos around lights at night, cause a decline in the population's use of these procedures. For instance, a 2020 article states that 20–40% of LASIK patients experience dry eye and itching after the operation, and 20% of LASIK patients have trouble with contrast, glare, and halos around light at night.

One of the significant factors influencing children's preference for orthokeratology lenses is the limited options available to them for correcting refractive errors. Another factor contributing to children's increased use of these lenses is eliminating the need to wear contact lenses and glasses during the day. Additionally, improvements in technology have made it easier to fit lenses, which has helped the general public become more aware of and adopt lenses, thereby driving the orthokeratology lens market CAGR.

The Global Orthokeratology Lens Market Industry is projected to experience substantial growth over the next decade. With a market value anticipated to reach 1.57 USD Billion by 2035, the industry is poised for expansion driven by various factors such as increasing myopia prevalence and technological advancements. The compound annual growth rate of 6.35% from 2025 to 2035 indicates a robust market trajectory. This growth is supported by rising consumer awareness and the adoption of non-surgical vision correction methods, which collectively contribute to the industry's positive outlook.

The rising prevalence of myopia globally is a key driver for the Global Orthokeratology Lens Market Industry. As studies indicate, myopia affects approximately 30% of the global population, and this figure is expected to rise significantly in the coming years. This surge in myopia cases is particularly pronounced in urban areas, where lifestyle factors contribute to increased screen time and reduced outdoor activities. Consequently, the demand for effective myopia management solutions, such as orthokeratology lenses, is likely to grow. The Global Orthokeratology Lens Market Industry is projected to reach 0.8 USD Billion in 2024, reflecting the urgent need for innovative corrective options.

Regulatory support and established standards for orthokeratology lenses are crucial factors driving the Global Orthokeratology Lens Market Industry. Government agencies and health organizations are increasingly recognizing the importance of safe and effective vision correction methods. This recognition leads to the development of guidelines and regulations that ensure the quality and safety of orthokeratology lenses. Such regulatory frameworks not only enhance consumer confidence but also encourage manufacturers to innovate and improve their products. The resulting market stability and growth potential are likely to benefit the Global Orthokeratology Lens Market Industry.

Growing awareness of vision health among consumers is significantly influencing the Global Orthokeratology Lens Market Industry. Educational campaigns and initiatives by healthcare professionals are increasingly informing the public about the benefits of early intervention in myopia management. This heightened awareness encourages parents to seek effective solutions for their children, thereby driving demand for orthokeratology lenses. As more individuals recognize the importance of maintaining optimal vision health, the market is likely to expand. The Global Orthokeratology Lens Market Industry is expected to experience a compound annual growth rate of 6.35% from 2025 to 2035, reflecting this trend.

Technological advancements in lens design are transforming the Global Orthokeratology Lens Market Industry. Innovations such as improved materials and manufacturing techniques enhance the comfort and effectiveness of orthokeratology lenses. For instance, the introduction of high-Dk materials allows for better oxygen permeability, which is crucial for overnight wear. These advancements not only improve patient satisfaction but also expand the market by attracting new users. As a result, the Global Orthokeratology Lens Market Industry is poised for growth, with projections indicating a market value of 1.57 USD Billion by 2035, driven by these technological improvements.

The rising adoption of non-surgical vision correction methods is a notable driver for the Global Orthokeratology Lens Market Industry. Many individuals prefer non-invasive options over surgical procedures due to concerns about risks and recovery times. Orthokeratology lenses offer a reversible and effective solution for myopia management without the need for surgery. This preference is particularly strong among parents seeking safe options for their children. As a result, the Global Orthokeratology Lens Market Industry is likely to see increased adoption rates, contributing to its overall growth and market expansion.

By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Orthokeratology Lens market accounted for USD 1.07 billion in 2022 and is anticipated to exhibit a significant CAGR growth over the study period. Recent advancements in orthokeratology lenses, the introduction of overnight ortho-K lenses, and flexibility and choice are some factors driving North American market growth. The increasing number of cases of visual impairment, combined with the increased use of orthokeratology lenses in Canada and the United States, is expected to create numerous growth opportunities throughout the region.

Moreover, major US market players such as Johnson & Johnson Vision, CooperVision, and Bausch & Lomb Inc are expected to increase their regional orthokeratology lens market share in the coming years. For example, in April 2021, Johnson & Johnson Vision partnered with Menicon to combine their expertise with the scope, science, and capabilities of J&J Vision to address the rising number of pediatric cases of myopia. Menicon will develop therapeutic contact lenses as part of the collaboration, while J&J Vision will focus on increasing the range of new products.

Furthermore, the major countries studied in the market report are the U.S., Germany, Canada, France, the UK, Spain, Italy, Japan, India, Australia, China, South Korea, and Brazil.

Figure 3: ORTHOKERATOLOGY LENS MARKET SHARE BY REGION 2023 (%)

Source: Primary Research, Secondary Research, Market Research Future Database, and Analyst Review

The European orthokeratology lens market has the second-largest market share, owing to the region's growing senior population and preference for correcting optical issues without surgery or traditional glasses. Moreover, rising government initiatives to increase the availability of high-quality treatment drive orthokeratology lens market demand in this region. The usage of orthokeratology lenses among medical professionals is anticipated to rise with the prevalence of ocular conditions like myopia and presbyopia. Technological advancements and increasing the number of products obtaining CE approval are further expected to boost regional growth.

Additionally, the German orthokeratology lens market held the largest market share, and the UK orthokeratology lens market was the fastest-growing market in the European region.

The Asia-Pacific Orthokeratology Lens Market is anticipated to grow at the fastest CAGR from 2022 to 2030, owing to the adoption of advanced products such as SEED and ProCornea and the region's growing senior population. Besides, an increase in awareness of eye disorders and the expansion and launches of significant players in this region are expected to drive market growth. In December 2020, for example, a Menicon Alpha Corporation subsidiary formed ALPHA (WUXI) Co. Ltd, a local Chinese Subsidiary, to increase the volume and business of orthokeratology lenses in China.

Moreover, the growing number of ophthalmic clinics and hospitals in Asian countries is expected to boost demand for orthokeratology lenses over the projected period. Furthermore, China’s orthokeratology lens market held the largest market share, and the Indian orthokeratology lens market was the fastest-growing market in the Asia-Pacific region.

Major market players are concentrating on meeting the growing demand for these orthokeratology lens treatments owing to the increasing prevalence of refractive errors worldwide. The orthokeratology lens industry offers non-surgical refractive error correction by altering the cornea's curvature with rigid lenses specially made for each patient. Industry players are also pursuing various strategic market development initiatives to expand their global footprint, including new product introductions, contractual arrangements, acquisitions and mergers, increased R&D investments, and collaborative efforts with other organizations.

The orthokeratology lens market’s major players, including Menicon Co. Ltd, CooperVision Inc, Euclid Systems Corporation, Alcon Inc, and others, are investing heavily in research and development to produce efficient and cost-effective orthokeratology lenses. Manufacturing these lenses locally to cut operating costs is one of the central business strategies used by production companies in the global orthokeratology lens industry to benefit consumers and expand the market sector.

Johnson & Johnson Vision (JJV) is a subsidiary of Johnson & Johnson that consists of two divisions: Johnson & Johnson Vision Care (Contact Lens) and Johnson & Johnson Surgical Vision. Among the services offered by the company are intraocular lenses, phacoemulsification systems, laser vision correction systems, viscoelastic, Microkeratomes, and associated products used in cataract and refractive surgery. The company operates in 24 countries and sells its products in about 60 nations. Johnson & Johnson Vision received FDA clearance for its first orthokeratology lens for myopia management in May 2021.

Also, CooperVision is a global contact lens company that serves eye care professionals and lens wearers in over 130 nations. They create various innovative soft contact lenses based on scientific and technological advances. It was founded in 1980 and is headquartered in California, United States. Cooper Companies Inc purchased C&E GP Specialists Inc, one of the leading orthokeratology lens manufacturers & distributors, to broaden CooperVision's specialty eye care business and address myopia's growing severity and prevalence.